Palatin Technologies
PTN
#10718
Rank
โ‚ฌ15.32 M
Marketcap
8,61ย โ‚ฌ
Share price
-5.13%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -โ‚ฌ5.33 Million

According to Palatin Technologies's latest financial reports the company's current earnings are โ‚ฌ12.88 Million. In 2025 the company made an earning of -โ‚ฌ8.3 Million, an increase over its 2024 earnings that were of -โ‚ฌ23.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ5.33 Million-35.85%
2025 -โ‚ฌ8.3 Million-64.29%
2024 -โ‚ฌ23.23 Million-16.9%
2023 -โ‚ฌ27.96 Million5.99%
2022 -โ‚ฌ26.38 Million-13.7%
2021 -โ‚ฌ30.57 Million33.25%
2020 -โ‚ฌ22.94 Million-172.11%
2019 โ‚ฌ31.8 M2352.33%
2018 โ‚ฌ1.29 M-94.13%
2017 โ‚ฌ22.09 M-154.92%
2016 -โ‚ฌ40.24 Million3.67%
2015 -โ‚ฌ38.82 Million878%
2014 -โ‚ฌ3.97 Million-72.64%
2013 -โ‚ฌ14.51 Million-33.11%
2012 -โ‚ฌ21.69 Million77.71%
2011 -โ‚ฌ12.21 Million
2003 -โ‚ฌ20.67 Million29.93%
2002 -โ‚ฌ15.91 Million36.18%
2001 -โ‚ฌ11.68 Million
1999 -โ‚ฌ9.7 Million6.04%
1998 -โ‚ฌ9.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.40 B-416,306.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.64 B-235,029.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ0.68 B-12,897.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚ฌ10.11 Million 87.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.16 B-3,151.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚ฌ0.11 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ0.10 B-1,958.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-โ‚ฌ25.43 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚ฌ49.97 Million 828.28%๐Ÿ‡บ๐Ÿ‡ธ USA